• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

2

CATEGORIES

  • 9
  • 4
  • 1
  • 1
  • 1
  • 1

PRICE

5
5
15
17

PUBLISHED

1
1
4
17

PRODUCT TYPE

16
1

Search "Acies Corporation" returned 17 results.

PRODUCT TITLE
(ACY)AEROCENTURY CORPORATION - Quantitative Valuation Report (ACY)AEROCENTURY CORPORATION - Quantitative Valuation Report - Product Thumbnail Image

(ACY)AEROCENTURY CORPORATION - Quantitative Valuation Report

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and useful report available. Our three models: Valuation Model, Forecast Model...

October 2014
Relapsed Multiple Myeloma - Pipeline Review, H2 2012 Relapsed Multiple Myeloma - Pipeline Review, H2 2012 - Product Thumbnail Image

Relapsed Multiple Myeloma - Pipeline Review, H2 2012

Relapsed Multiple Myeloma – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Relapsed Multiple Myeloma - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline....

September 2012
FROM

Ischemia - Pipeline Review, H2 2013

Ischemia - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Ischemia - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

July 2013
FROM

Relapsed Multiple Myeloma - Pipeline Review, H2 2013

Relapsed Multiple Myeloma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Relapsed Multiple Myeloma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

September 2013
FROM

Refractory Multiple Myeloma - Pipeline Review, H2 2013

'Refractory Multiple Myeloma - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline This report provides information on the therapeutic development for Refractory...

July 2013
FROM
Multiple Myeloma Therapeutics - Global Strategic Business Report Multiple Myeloma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Multiple Myeloma Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for Multiple Myeloma Therapeutics in US$ Million The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World Annual estimates...

October 2011
FROM

Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2013

Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic...

July 2013
FROM

Mantle Cell Lymphoma - Pipeline Review, H2 2013

Mantle Cell Lymphoma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Mantle Cell Lymphoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

July 2013
FROM
Ischemia - Pipeline Review, H1 2013 Ischemia - Pipeline Review, H1 2013 - Product Thumbnail Image

Ischemia - Pipeline Review, H1 2013

Ischemia – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Ischemia - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

February 2013
FROM
Blood Cancer - Pipeline Review, H2 2012 Blood Cancer - Pipeline Review, H2 2012 - Product Thumbnail Image

Blood Cancer - Pipeline Review, H2 2012

Blood Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Blood Cancer - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides...

December 2012
FROM
Refractory Multiple Myeloma - Pipeline Review, H2 2012 Refractory Multiple Myeloma - Pipeline Review, H2 2012 - Product Thumbnail Image

Refractory Multiple Myeloma - Pipeline Review, H2 2012

Refractory Multiple Myeloma – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Refractory Multiple Myeloma - Pipeline Review, H2 2012', provides an overview of the Refractory Multiple Myeloma...

July 2012
FROM
Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2012 Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2012 - Product Thumbnail Image

Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2012

Multiple Myeloma (Kahler's Disease) – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2012', provides an overview of the Multiple...

January 2012
FROM
Ischemia - Pipeline Review, H1 2012 Ischemia - Pipeline Review, H1 2012 - Product Thumbnail Image

Ischemia - Pipeline Review, H1 2012

Ischemia – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Ischemia - Pipeline Review, H1 2012', provides an overview of the Ischemia therapeutic pipeline. This report provides information...

January 2012
FROM
Ischemia - Pipeline Review, H2 2012 Ischemia - Pipeline Review, H2 2012 - Product Thumbnail Image

Ischemia - Pipeline Review, H2 2012

Ischemia – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Ischemia - Pipeline Review, H2 2012', provides an overview of the Ischemia therapeutic pipeline. This report provides information...

July 2012
FROM

T-Cell Lymphomas - Pipeline Review, H2 2013

T-Cell Lymphomas - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'T-Cell Lymphomas - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

October 2013
FROM

Thalassemia - Pipeline Review, H1 2014

Thalassemia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Thalassemia - Pipeline Review, H1 2014’, provides an overview of the Thalassemia’s therapeutic pipeline. This report provides...

June 2014
FROM

Depression - Pipeline Review, H1 2014

Depression - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Depression - Pipeline Review, H1 2014’, provides an overview of the Depression’s therapeutic pipeline. This report provides...

April 2014
FROM
Loading Indicator